Brief: Resonance Health Says Contracted For Two New Clinical Trials
11/11/2022 24:19
Nov 11 (Reuters) - Resonance Health RHT.AX :
* RESONANCE HEALTH CONTRACTED FOR TWO NEW CLINICAL TRIALS
* VALUE OF NEW CONTRACTS IS UP TO AU $1.5M
* CONTRACTED WITH 2 NEW PHARMACEUTICAL CUSTOMERS TO PROVIDE
FERRISCAN, CARDIAC-T2 & RELATED ANALYSIS SERVICES FOR CLINICAL
TRIALS
Source text for Eikon: ID:nASX76pTFM
Further company coverage: RHT.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Resonance Health
See all newsBrief: Resonance Health Halts Trading In Resonance Health Securities Pending Announcement
Australia's Resonance Health gains on IAG agreement
Brief: Resonance Health Enters Global Strategic Alliance & MSA With Image Analysis Group
Brief: Resonance Health Posts Profit Attributable Of A$1.5 Million
Brief: Resonance Health Says It Expects FY27 Normalised EBITDA Of AUD 2.6 To 3.6 Million